The first rare and fatal case of invasive aspergillosis of spinal cord due to Aspergillus nidulans in an Iranian child with chronic granulomatosis disease: review of literature

Document Type : Case report


1 Student Research Committee, Invasive Fungi Research Center, Mazandaran University of Medical Sciences, Sari, Iran

2 Invasive Fungi Research Center, Mazandaran University of Medical Sciences, Sari, Iran

3 Department of Medical Mycology and Parasitology, Isfahan University of Medical Sciences, Isfahan, Iran

4 Cellular and Molecular Research center, Yasuj University of Medical Sciences, Yasuj, Iran

5 Student Research Committee, Invasive Fungi Research Center, Sari, Iran

6 Department of Clinical pharmacy, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

7 Department of Infectious Diseases, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran


Background and Purpose: Invasive aspergillosis (IA) of the central nervous system (CNS) is a devastating complication which is rarely reported in immunocompromised children.
In this case presentation, we reported a rare and fatal IA with spinal cord involvement in a 10-year-old child with X-linked chronic granulomatosis disease (CGD).
Case report: The child had a previous history of pulmonary tuberculosis. A cervical spine X-ray revealed the involvement of cervical vertebrae (T4/T5) and ribs causing spinal cord compression and epidural abscess. The patient underwent a decompressive laminectomy and mass removal. The histopathology and culture results suggested IA. Despite the aggressive and prolonged therapy, he died within one year. Aspergillus nidulans was identified as the causative agent based on morphological and molecular studies.
Conclusion: This synopsis represents the aggressive behavior of infection caused by A. nidulans in the CGD patient.


1. Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med Mycol. 2005; 43(Suppl 1):S247-59.
2. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T,
Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008; 126(2):155-64.
3. Segal BH. Invasive aspergillosis in chronic granulomatous disease. Aspergillosis: from diagnosis to prevention. New York: Springer; 2009. P. 527-43.
4. Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2014; 60(8):1176-83.
5. Chen AJ, Frisvad JC, Sun BD, Varga J, Kocsubé S, Dijksterhuis J, et al. Aspergillus section Nidulantes (formerly Emericella): polyphasic taxonomy, chemistry and biology. Stud Mycol. 2016; 84:1-118.
6. Yu J, Mu X, Li R. Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin. J Clin Microbiol. 2013; 51(4):1327-9.
7. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine. 1998; 77(5):345-54.
8. Verweij PE, Varga J, Houbraken J, Rijs AJ, VerduynLunel FM, Blijlevens NM, et al. Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis. 2008; 14(4):566-72.
9. Baylet R, Basset A. Aspergillus nidulans, agent of mycetoma. Bull Soc Pathol Exot Filiales. 1968; 61(3):359-65.
10. Doby JM, Kombila-Favry M. Presence of sexual forms (cleistothecia and Hülle cells) in a case of human maxillary sinus aspergillosis caused by Aspergillus nidulans in association with Aspergillus fumigatus. Mycopathologia. 1978; 64(3):157-63.
11. Joshi KR, Mathur DR, Sharma JC, Vyas MC, Sanghvi A. Mycetoma caused by Aspergillus nidulans in India. J Trop Med Hyg. 1985; 88(1):41-4.
12. Henriet SS, Verweij PE, Warris A. Aspergillus nidulans and chronic granulomatous disease: a unique host–pathogen interaction. J Infect Dis. 2012; 206(7):1128-37.
13. Sabino R, Veríssimo C, Parada H, Brandão J, Viegas C, Carolino E, et al. Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources. Med Mycol. 2014; 52(5):519-29.
14. Lucas GM, Tucker P, Merz WG. Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia. Clin Infect Dis. 1999; 29(6):1594-6.
15. Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis. 2004; 8(2):103-10.
16. Blumental S, Mouy R, Mahlaoui N, Bougnoux ME, Debré M, Beauté J, et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis. 2011; 53(12):e159-69.
17. Sheth NK, Varkey B, Wagner DK. Spinal cord aspergillus invasion--complication of an aspergilloma. Am J Clin Pathol. 1985; 84(6):763-9.
18. van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PloS One. 2009; 4(4):e5234.
19. Nouripour-Sisakht S, Mirhendi H, Shidfar M, Ahmadi B, Rezaei-Matehkolaei A, Geramishoar M, et al. Aspergillus species as emerging causative agents of onychomycosis. J Mycol Med. 2015; 25(2):101-7.
20. Arendrup MC, Guinea J, Cuenca-Estrella M, Meletiadis J, Mouton JW, Lagrou K, et al. Eucast Definitive Document E. DEF 9.3. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. Vaxjo, Sweden: European Committee for Antimicrobial Susceptibility Testing; 2015.
21. Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000; 137(5):687-93.
22. Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 2001; 344(12):881-8.
23. Notheis G, Tarani L, Costantino F, Jansson A, Rosenecker J, Friederici D, et al. Posaconazole for treatment of refractory invasive fungal disease. Mycoses. 2006; 49(Suppl 1):37-41.
24. Malech HL. Progress in gene therapy for chronic granulomatous disease. J Infect Dis. 1999; 179(Suppl 2):S318-25.
25. Tsiodras S, Falagas ME. Clinical assessment and medical treatment of spine infections. Clin Orthop Relat Res. 2006; 444:38-50.
26. Sambatakou H, Guiver M, Denning D. Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole. Eur J Clin Microbiol Infect Dis. 2003; 22(11):681-5.
27. Gamaletsou MN, Rammaert B, Bueno MA, Moriyama B, Sipsas NV, Kontoyiannis DP, et al. Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome. J Infect. 2014; 68(5):478-93.
28. Mamishi S, Zomorodian K, Saadat F, Gerami-Shoar M, Tarazooie B, Siadati SA. A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-γ. Ann Clin Microbiol Antimicrob. 2005; 4(1):4.
29. Henriet SS, Hermans PW, Verweij PE, Simonetti E, Holland SM, Sugui JA, et al. Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms. Infect Immun. 2011; 79(2):767-73.
30. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002; 347(6):408-15.
31. Siopi M, Siafakas N, Vourli S, Mouton JW, Zerva L, Meletiadis J. Dose optimization of voriconazole/ anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis. J Antimicrob Chemother. 2016; 71(11):3135-47.
32. Redmond A, Carre IJ, Biggart JD, Mackenzie DW. Aspergillosis (Aspergillus nidulans) involving bone. J Pathol Bacteriol. 1965; 89(1):391-5.
33. Bujak JS, Kwon-Chung KJ, Chusid MJ. Osteomyelitis and pneumonia in a boy with chronic granulomatous disease of childhood caused by a mutant strain of Aspergillus nidulans. Am J Clin Pathol. 1974; 61(3):361-7.
34. Altman A. Thoracic wall invasion secondary to pulmonary aspergillosis: a complication of chronic granulomatous disease of childhood. Am J Roentgenol. 1977; 129(1):140-2.
35. White CJ, Kwon-Chung K, Gallin JI. Chronic granulomatous disease of childhood: an unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol. 1988; 90(3):312-6.
36. Sponseller PD, Malech HL, McCarthy EF Jr, Horowitz SF, Jaffe G, Gallin JI. Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg Am. 1991; 73(1):37-51.
37. Kim M, Shin JH, Suh SP, Ryang DW, Park CS, Kim CS, et al. Aspergillus nidulans infection in a patient with chronic granulomatous disease. J Korean Med Sci. 1997; 12(3):244-8.
38. Ozsahin H, Von Planta M, Müller I, Steinert HC, Nadal D, Lauener R, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor–mobilized granulocytes, and liposomal amphotericin-B. Blood. 1998; 92(8):2719-24.
39. Sastry J, Kakakios A, Tugwell H, Shaw PJ. Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatr Blood Cancer. 2006; 47(3):327-9.
40. Dellepiane RM, Tortorano AM, Liotto N, Laicini E, Di Landro G, Carnelli V, et al. Invasive Aspergillus nidulans infection in a patient with chronic granulomatous disease. Mycoses. 2008; 51(5):458-60.
41. Bukhari E, Alrabiaah A. First case of extensive spinal cord infection with Aspergillus nidulans in a child with chronic granulomatous disease. J Infect Dev Ctries. 2009; 3(4):321-3.
42. Khalid M, Ali SA. Fungal osteomyelitis in a patient with chronic granulomatous disease: Case report and review of the literature. J Pak Med Assoc. 2018; 68(9):1387-90.
Volume 6, Issue 1
March 2020
Pages 55-60
  • Receive Date: 30 September 2019
  • Accept Date: 22 January 2020
  • First Publish Date: 01 March 2020
  • Publish Date: 01 March 2020